The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 6,830 | 21,471 |
| Depreciation and amortization | 2,029 | 4,506 |
| Net amortization of premiums and (accretion of discounts) | -110 | -175 |
| Provision for credit losses | -49 | 9,899 |
| Proceeds from sales of loans originated to sell | 0 | -12,224 |
| Net change in mortgage loans held for sale | 16,092 | 18,344 |
| Net gains on mortgage banking | 8,887 | 13,508 |
| Net gains on sale of loans | 249 | 210 |
| Proceeds from sales of assets held for sale | -1,326 | -982 |
| Loss on bank premises and equipment and assets held for sale | 80 | 111 |
| Earnings on bank-owned life insurance | 456 | 863 |
| Gain on bank-owned life insurance death benefit | 0 | 0 |
| Stock-based compensation expense | 12 | 49 |
| Gains on panacea financial holdings investment | 294 | 32,028 |
| Gains on other investments | 381 | -255 |
| Deferred income tax expense (benefit) | -1,780 | -5,594 |
| Net change in fair value of loan derivative | 768 | 3,334 |
| Net (increase) decrease in other assets | -1,996 | 2,542 |
| Net increase (decrease) in other liabilities | 96 | 2,308 |
| Proceeds from bank-owned life insurance death benefit | - | 0 |
| Net cash and cash equivalents (used in) provided by operating activities | -11,381 | -6,587 |
| Purchases of securities available-for-sale | 0 | 18,460 |
| Proceeds from paydowns, maturities and calls of securities available-for-sale | 8,935 | 18,680 |
| Proceeds from paydowns, maturities and calls of securities held-to-maturity | 294 | 585 |
| Net increase in frb and fhlb stock | -4,037 | 39 |
| Net change in loans held for investment | 125,273 | 173,799 |
| Purchases of other investments | - | -164 |
| Proceeds from sales of loans initially originated to be held for investment | 4,191 | 52,902 |
| Proceeds from sale of panacea financial holdings investment | 22,091 | - |
| Proceeds from sale of other investment | 432 | - |
| Net (increase) decrease in other investments | -49 | - |
| Net cash and cash equivalents used in investing activities | -93,580 | -119,889 |
| Net increase in deposits | -6,321 | 162,091 |
| Increase in securities sold under agreements to repurchase | 416 | -452 |
| Repayments of secured borrowings, net | -1,046 | -746 |
| Repayment of short-term fhlb advances | 0 | 0 |
| Cash dividends paid on common stock | 2,464 | 4,945 |
| Repurchase of common stock | 0 | 807 |
| Proceeds from exercised stock options | 15 | 0 |
| Repurchase of restricted stock | 0 | 0 |
| Increase in short-term fhlb advances | 85,000 | - |
| Issuance of panacea financial holdings stock, net of costs | 0 | 0 |
| Net cash and cash equivalents provided by financing activities | 74,768 | 156,045 |
| Net change in cash and cash equivalents | -30,193 | 29,569 |
| Cash and cash equivalents at beginning of period | 64,505 | - |
| Cash and cash equivalents at end of period | 63,881 | - |
Primis Financial Corp. (FRST)
Primis Financial Corp. (FRST)